Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 1;82(5):481-491.
doi: 10.1001/jamapsychiatry.2025.0033.

Circulating Blood-Based Proteins in Psychopathology and Cognition: A Mendelian Randomization Study

Affiliations

Circulating Blood-Based Proteins in Psychopathology and Cognition: A Mendelian Randomization Study

Upasana Bhattacharyya et al. JAMA Psychiatry. .

Abstract

Importance: Peripheral (blood-based) biomarkers for psychiatric illness could benefit diagnosis and treatment, but research to date has typically been low throughput, and traditional case-control studies are subject to potential confounds of treatment and other exposures. Large-scale 2-sample mendelian randomization (MR) can examine the potentially causal impact of circulating proteins on neuropsychiatric phenotypes without these confounds.

Objective: To identify circulating proteins associated with risk for schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD) as well as cognitive task performance (CTP).

Design, setting, and participants: In a 2-sample MR design, significant proteomic quantitative trait loci were used as candidate instruments, obtained from 2 large-scale plasma proteomics datasets: the UK Biobank Pharma Proteomics Project (2923 proteins per 34 557 UK individuals) and deCODE Genetics (4719 proteins per 35 559 Icelandic individuals). Data analysis was performed from November 2023 to November 2024.

Exposure: Genetic influence on circulating levels of proteins in plasma.

Main outcomes and measures: Outcome measures were summary statistics drawn from recent large-scale genome-wide association studies for SCZ (67 323 cases and 93 456 controls), BD (40 463 cases and 313 436 controls), MDD (166 773 cases and 507 679 controls), and CTP (215 333 individuals). MR was carried out for each phenotype, and proteins that showed statistically significant (Bonferroni-corrected P < .05) associations from MR analysis were used for pathway, protein-protein interaction, drug target enrichment, and potential druggability analysis for each outcome phenotype separately.

Results: MR analysis revealed 113 Bonferroni-corrected associations (46 novel) involving 91 proteins across the 4 outcome phenotypes. Immune-related proteins, such as interleukins and complement factors, showed pleiotropic effects across multiple outcome phenotypes. Drug target enrichment analysis provided support for repurposing of anti-inflammatory agents for SCZ, amantadine for BD, retinoic acid for MDD, and duloxetine for CTP.

Conclusions and relevance: Identifying potentially causal effects of circulating proteins on neuropsychiatric phenotypes suggests potential biomarkers and offers insights for the development of innovative therapeutic strategies. The study also reveals pleiotropic effects of many proteins across different phenotypes, indicating shared etiology among serious psychiatric conditions and cognition.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Chen reported owning stock from Biogen outside the submitted work. No other disclosures were reported.

References

    1. Harsanyi S, Kupcova I, Danisovic L, Klein M. Selected biomarkers of depression: what are the effects of cytokines and inflammation? Int J Mol Sci. 2022;24(1):578. doi:10.3390/ijms24010578 - DOI - PMC - PubMed
    1. Upthegrove R, Khandaker GM. Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia. Curr Top Behav Neurosci. 2020;44:49-66. doi:10.1007/7854_2018_88 - DOI - PubMed
    1. Vega-Núñez A, Gómez-Sánchez-Lafuente C, Mayoral-Cleries F, et al. . Clinical value of inflammatory and neurotrophic biomarkers in bipolar disorder: a systematic review and meta-analysis. Biomedicines. 2022;10(6):1368. doi:10.3390/biomedicines10061368 - DOI - PMC - PubMed
    1. Yang C, Fagan AM, Perrin RJ, Rhinn H, Harari O, Cruchaga C. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes. Genome Med. 2022;14(1):140. doi:10.1186/s13073-022-01140-9 - DOI - PMC - PubMed
    1. Gu X, Dou M, Su W, et al. . Identifying novel proteins underlying schizophrenia via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data. BMC Med. 2022;20(1):474. doi:10.1186/s12916-022-02679-5 - DOI - PMC - PubMed